Singapore Reveals Phase-In Plans For eCTD
Executive Summary
The Health Sciences Authority will seek industry’s feedback on the plans it has for introducing in Singapore the electronic format of the common technical document that drug companies use to make their regulatory submission.
You may also be interested in...
Industry Welcomes Mandatory eCTD In Australia, But With Caveats
The Australian regulator, TGA, is currently assessing responses to last year’s consultation on the mandatory use of the eCTD for prescription drug submissions. Industry is mostly happy with the proposal, but has some concerns over the implementation process and certain technical issues.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug
The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.